menu search

ASXC / Asensus Surgical (ASXC) Reports Q1 Loss, Misses Revenue Estimates

Asensus Surgical (ASXC) Reports Q1 Loss, Misses Revenue Estimates
Asensus Surgical (ASXC) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.07 per share a year ago. Read More
Posted: May 11 2023, 19:02
Author Name: Zacks Investment Research
Views: 111841

ASXC News  

Best Penny Stocks To Buy Now? 10 Under $1 To Watch

By PennyStocks
September 13, 2023

Best Penny Stocks To Buy Now? 10 Under $1 To Watch

Let's be honest – penny stocks priced at less than a buck hold an irresistible appeal. Even a small investment could potentially lead to insane retu more_horizontal

Best Penny Stocks To Buy Now? 7 Under $1 To Watch

By PennyStocks
September 11, 2023

Best Penny Stocks To Buy Now? 7 Under $1 To Watch

Penny stocks priced under $1 per share have attracted a dedicated following among traders seeking massive returns. While penny stocks are inherently h more_horizontal

Why Is Asensus Surgical (ASXC) Stock Up 18% Today?

By InvestorPlace
September 7, 2023

Why Is Asensus Surgical (ASXC) Stock Up 18% Today?

Asensus Surgical (NYSEMKT: ASXC ) stock is rising higher on Thursday as investors react to news of a collaboration with Nvidia (NASDAQ: NVDA ). The bi more_horizontal

Best Penny Stocks To Buy Now? 3 Under $1 To Watch

By PennyStocks
September 7, 2023

Best Penny Stocks To Buy Now? 3 Under $1 To Watch

Penny stocks, typically priced below $5, have become a popular choice for day traders due to their potential for rapid gains. These stocks can offer m more_horizontal

Asensus Surgical to Participate in the H.C. Wainwright 25th Annual Global Investment Conference and 2023 Cantor Global Healthcare Conference

By GlobeNewsWire
September 5, 2023

Asensus Surgical to Participate in the H.C. Wainwright 25th Annual Global Investment Conference and 2023 Cantor Global Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, more_horizontal

Asensus Surgical (ASXC) Q2 Loss Widens, Revenues In Line

By Zacks Investment Research
August 11, 2023

Asensus Surgical (ASXC) Q2 Loss Widens, Revenues In Line

Asensus Surgical (ASXC) reports a significant increase in total surgical procedures completed utilizing the Senhance System. more_horizontal

Asensus Surgical (ASXC) Reports Q2 Loss, Tops Revenue Estimates

By Zacks Investment Research
August 10, 2023

Asensus Surgical (ASXC) Reports Q2 Loss, Tops Revenue Estimates

Asensus Surgical (ASXC) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to los more_horizontal

Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 10, 2023

By GlobeNewsWire
August 1, 2023

Asensus Surgical, Inc. Schedules Second Quarter Financial and Operating Results Conference Call for August 10, 2023

RESEARCH TRIANGLE PARK, N.C., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a medical device company that is digiti more_horizontal


Search within

Pages Search Results: